Skip to main content
Clinical Trials/CTRI/2023/09/057611
CTRI/2023/09/057611
Not yet recruiting
Phase 3

Functional recovery assessment of persons with Acute Ischaemic stroke with homoeopathic intervention as an add-on to the standard treatment – A double blind randomised controlled trial - AIS-HOM

Central Council for Research in Homoeopathy0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Central Council for Research in Homoeopathy
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • 1\. Cases of any gender, more than 18 years of age, diagnosed with Acute Ischemic stroke \[(ICD\-11\) 8B11: Cerebral ischaemic stroke] having symptoms for \>6 hours to 7 days, on the basis of neurological clinical evaluation and neuro imaging.
  • 2\. Acute AIS patients with a history of AIS episode with 90% recovery of residual effects of previous episode.
  • 3\. Modified Rankin Scale (mRS) score from 2 to 5\.
  • 4\. Written Informed consent from the patient.

Exclusion Criteria

  • 1\. Pregnant or lactating females.
  • 2\. Minor or rapidly improving stroke symptoms with complete recovery within 6 hours.
  • 3\. Cases of haemorrhagic stroke (subarachnoid haemorrhage, venous infarct), Transient Ischemic Attack (TIA).
  • 4\. Intraspinal surgery, serious head trauma (history or as a result of present episode of AIS).
  • 5\. Having previously diagnosed or clinically established disorders like recrudescence, migraine aura, seizures, peripheral vertigo and dizziness or Multiple sclerosis (MS) which may mimic AIS.
  • 6\. Neoplasia and other intracranial space\-occupying lesions.
  • 7\. Severe, advanced cases of uncontrolled systemic diseases like cardiovascular, endocrinal, renal diseases, metabolic abnormalities like hyponatremia, hypocalcemia, hypoglycemia, uremia, or other disorders.

Outcomes

Primary Outcomes

Not specified

Similar Trials